Seocho, Seoul-t'ukpyolsi, South Korea Related Funds
| Fund Name | Location |
| Al.Pe Invest | - |
| CAC CAPITAL | - |
| Cheng Tian Capital I | China, Hong Kong, Hong Kong Island |
| China Steel | Kaohsiung, Taiwan |
| Corrum Capital Management | Charlotte, North Carolina, United States |
| Court Square Ventures | Charlottesville, United States, Virginia |
| Fusion LA | California, Santa Monica, United States |
| Hasso Plattner Institute | Brandenburg, Germany, Potsdam |
| HDFC Mutual Fund | India, Maharashtra, Mumbai |
| IDF Capital SA | Gauteng, Johannesburg, South Africa |
| Iowa Corn Opportunities | Iowa, Johnston, United States |
| Kale United | Stockholm, Stockholm County, Sweden |
| Moai Capital Venture | Italy, Lombardy, Milan |
| Nantong Ledong Qiye Guanli Hehuo Qiye (Youxian Hehuo) | China, Jiangsu, Nantong |
| Rokk3r | Florida, Miami, United States |
| University of Chicago New Venture Challenge | Chicago, Illinois, United States |
| Vintage Investment Partners | Herzliya, Israel, Tel Aviv |
| Wiel Brien Investments, LLC, | - |
| Zhuhai Zhongle | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Good Pharm | 16 Jan 2023 | South Korea, Gangwon-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Good Pharm | 16 Jan 2023 | South Korea, Gangwon-do, South Korea |
